17, 2013-- BioLineRx Ltd. (NASDAQ: BLRX)(TASE: BLRX), a biopharmaceutical development company, announced today that it has entered into an at-the-market (ATM) sales agency agreement with Stifel.

BioLineRx's current portfolio consists of seven clinical stage candidates: BL-1040, for prevention of pathological cardiac remodeling following a myocardial infarction, which has been out-licensed to Ikaria Inc., is currently undergoing a pivotal CE ...

BioLineRx Reports First Quarter 2013 Results. JERUSALEM--(BUSINESS WIRE)-- BioLineRx Ltd. (NAS: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended March 31, 2013.

JERUSALEM, May 09, 2013 (BUSINESS WIRE) -- BioLineRx Ltd. (NASDAQ:BLRX) (tase:BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.

... 02:43:00 PM EDT. Vote up. loading. (RTTNews.com) - BioLineRx Ltd.( BLRX ) will present at the 12th Annual Needham Healthcare Conference in New York.

BioLineRx Ltd. logo BioLineRx (NASDAQ: BLRX) posted its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.02) by $0.18, Analyst Ratings Network ...

BioLineRX Ltd. is an Israel-based company engaged in identifying and following the critical pathway to commercialization of therapeutic compounds.

After disappointing investors in March by terminating a Phase 2/3 clinical trial of an anti-psychotic drug candidate for the treatment of schizophrenia, BioLineRx (NASDAQ: BLRX) bounced back in April, posting positive Phase 2a results with an oral ...

The company is run by Dr. Yona Gefen, , former director of product development BioLineRx. Chairman is Ya'acov Michlin, CEO of ... Another Israeli attempt, made by 'Allon Therapeutics Inc.' failed to achieve the desired result.' Since that early ...

... INC Q1 BIOTECHNOLOGY USD -0.38 -0.36 0.02 5.0 6.5 1.5 AVIV REIT INC Q1 INVESTMENTS USD -0.36 -0.33 0.03 33.0 34.7 1.7 BIOCRYST PHARMACEUTICALS Q1 BIOTECHNOLOGY USD -0.15 -0.09 0.06 1.3 3.6 2.2 BIOLINE RX LTD Q1 HOME ...